Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01782820Completed

Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium

Role: lead

NCT03605628Not ApplicableCompleted

Influence of Analgesia and Neuromuscular Block on Abdominal Distension and Operating Conditions Laparoscopic Operations

Role: lead

NCT05005676Not ApplicableUnknown

Evaluation of the New Acceleromyograph TOF 3D

Role: lead

NCT01849211Not ApplicableCompleted

Influence of Neuromuscular Block on Mask Ventilation

Role: lead

NCT01849198Not ApplicableCompleted

Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation

Role: lead

NCT01843153Phase 4Completed

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

Role: lead

All 6 trials loaded